TY - JOUR
T1 - The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias
T2 - Etiologic Implications
AU - Hemminki, Kari
AU - Försti, Asta
AU - Tuuminen, Raimo
AU - Hemminki, Otto
AU - Goldschmidt, Hartmut
AU - Sundquist, Kristina
AU - Sundquist, Jan
AU - Li, Xinjun
N1 - Funding Information:
We are grateful to Patrick Reilly for language editing of the manuscript. Supported by Deutsche Krebshilfe, the Multiple Myeloma Research Foundation, the Harald Huppert Foundation and the German Ministry of Education and Science (01ZX1309B).
PY - 2016/6/22
Y1 - 2016/6/22
N2 - Plasma cell dyscrasias, including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), Waldenström macroglobulinemia (WM) and light chain AL amyloidosis, are characterized by clonal expansion of plasma cells which produce a vast amount of an immunoglobulin-derived M-protein. We noted that MGUS diagnosis often coincided with diagnoses of senile cataract and glaucoma and tested the associations of MGUS, MM, WM and AL amyloidosis with subsequent eye diseases identified from the Swedish patient registers between 1997 and 2012. Standardized incidence ratios (SIRs) for senile cataract was significantly increased to 1.80 after MGUS, 1.70 after MM, 1.85 after WM and 2.31 after AL amyloidosis. The SIR for glaucoma was 1.60 after MGUS, 1.76 after WM and 2.18 after AL amyloidosis. All SIRs decreased systematically from age below 60 years to over 79 years, but most risks were also significant in age group over 79 years. The M-protein and the related increase in blood viscosity could be a novel etiologic discovery for these common eye diseases. As MGUS prevalence is around 3% at 60 years and close to 10% at age over 80 years, its contribution to the eye disease burden is expected to be remarkably high.
AB - Plasma cell dyscrasias, including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), Waldenström macroglobulinemia (WM) and light chain AL amyloidosis, are characterized by clonal expansion of plasma cells which produce a vast amount of an immunoglobulin-derived M-protein. We noted that MGUS diagnosis often coincided with diagnoses of senile cataract and glaucoma and tested the associations of MGUS, MM, WM and AL amyloidosis with subsequent eye diseases identified from the Swedish patient registers between 1997 and 2012. Standardized incidence ratios (SIRs) for senile cataract was significantly increased to 1.80 after MGUS, 1.70 after MM, 1.85 after WM and 2.31 after AL amyloidosis. The SIR for glaucoma was 1.60 after MGUS, 1.76 after WM and 2.18 after AL amyloidosis. All SIRs decreased systematically from age below 60 years to over 79 years, but most risks were also significant in age group over 79 years. The M-protein and the related increase in blood viscosity could be a novel etiologic discovery for these common eye diseases. As MGUS prevalence is around 3% at 60 years and close to 10% at age over 80 years, its contribution to the eye disease burden is expected to be remarkably high.
UR - http://www.scopus.com/inward/record.url?scp=84975749478&partnerID=8YFLogxK
U2 - 10.1038/srep28500
DO - 10.1038/srep28500
M3 - Article
C2 - 27328652
AN - SCOPUS:84975749478
SN - 2045-2322
VL - 6
JO - Scientific Reports
JF - Scientific Reports
M1 - 28500
ER -